Ulimorelin

DRUG4 trials

Sponsors

Norgine, Lyric Pharmaceuticals

Conditions

Digestive System DisordersEnteral Feeding Intolerance (EFI)Healthy Subjects

Phase 1

Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers

CompletedNCT01405612

NorgineDigestive System Disorders

Start: 2011-06-30End: 2011-07-31Updated: 2012-10-16

Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects

CompletedNCT01405599

NorgineDigestive System Disorders

Start: 2011-06-30End: 2011-10-31Updated: 2012-10-16

A Study to Assess Ulimorelin in Healthy Subjects

CompletedNCT02993055

Lyric PharmaceuticalsHealthy Subjects

Start: 2015-01-31End: 2015-11-30Updated: 2018-05-30

Phase 2

Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial

CompletedNCT02784392

Lyric PharmaceuticalsEnteral Feeding Intolerance (EFI)

Start: 2016-10-31End: 2018-03-31Updated: 2018-03-07

Related Papers

The effects of ulimorelin, a ghrelin agonist, on liquid gastric emptying and colonic transit in humans

Neurogastroenterology & Motility2020-02-0310 citations